RPL10 and familial pancreatic carcinoma: Previously, using dimethyl-amino-parthenolide (DMAPT) as a molecular probe, we found that DMAPT can directly bind RPL10 and synergistically exhibit its anti-proliferative activity from the inhibition of p65 in pancreatic cancer cells [29].